Burning Rock Biotech Ltd expected to post a loss of CNY2.35 a share - Earnings Preview

Burning Rock Biotech

14/11/2022 13:42

* Burning Rock Biotech Ltd  BNR.OQ   BNR.O  is expected
to show a
rise in quarterly revenue when it reports  results on November
16. 
    * The Guangzhou Guangdong-based  company is expected to
report  a
21.2% increase in revenue to CNY153.5 million from CNY126.62
million a year ago, according to the estimate from one analyst,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Burning Rock
Biotech Ltd
is for a loss of CNY2.35 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Burning
Rock
Biotech Ltd is $6.7​, above​ its last closing price of $2.30.
​​​

This summary was machine generated November 14 at 13:42 GMT. 
All figures in Chinese yuan renminbi  unless otherwise stated